SecBot SecBot
S-1 ·Filed Oct 26, 2026

TRAX

First Tracks Biotherapeutics, Inc.
NEUTRAL
Impact 4/10
Processed1h 31m ago SEC0001193125-26-431033
IPO registration

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
S-1 Filing (Primary)0001193125-26-431033
Document: d191573dexfilingfees.htm0001193125-26-431033
Document: d191573dex51.htm0001193125-26-431033
Document: d191573dex231.htm0001193125-26-431033
Document: 0001193125-26-431033-index-headers.html0001193125-26-431033
Document: 0001193125-26-431033-index.html0001193125-26-431033
Document: 0001193125-26-431033.txt0001193125-26-431033
20 reports for TRAX
Performance horizon
80% Hit rate @ T+1 4 of 5 directional calls Went positive at some point 4 of 5 best @ T+5▲ +30.21%Oct 13, 2026
Filters
Rows
Reports for TRAX — sortable, filterable
TypeNow
Oct 26, 2026
today
S-1
NEUTRAL ★ 4/10
$43.80awaiting T+1—$44.05 (+0.57%)
Oct 20, 2026
5d ago
8-K
NEUTRAL ★ 2/10
$42.77 $43.14▲ +0.87%▲ +2.05%$44.05 (+2.99%)
Oct 15, 2026
10d ago
8-K
BEARISH ★ 6/10
$34.46 $36.28▼ −5.28%▼ −4.86%$44.05 (−27.83%)
Oct 15, 2026
11d ago
Press Release
BEARISH ★ 6/10
$36.04 $34.46▲ +4.38%▲ +3.28%$44.05 (−22.23%)
Oct 13, 2026
13d ago
8-K
BULLISH ★ 7/10
$31.68 $34.13▲ +7.73%▲ +8.81%$44.05 (+39.05%)
Aug 12, 2026
10w ago
8-K
BULLISH ★ 6/10
$44.03 $44.04▲ +0.02%▲ +0.22%$44.05 (+0.05%)
Aug 12, 2026
10w ago
Press Release
BULLISH ★ 6/10
$44.03 $44.04▲ +0.02%▲ +0.22%$44.05 (+0.05%)
Aug 7, 2026
11w ago
3/A
NEUTRAL ★ 2/10
$47.92 $46.75▼ −2.44%▼ −2.12%$44.05 (−8.08%)
Jun 22, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$17.78 $16.69▼ −6.13%▼ −6.08%$44.05 (+147.75%)
May 14, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$16.90 $17.79▲ +5.27%▲ +5.33%$44.05 (+160.65%)
Showing 10 of 20

US Market Status

Market Closed — Opens in 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 26, 2026

Fresh TRAX Intelligence

Analysis is for subscribers only.

First Tracks Biotherapeutics filed an S-1 registration statement for the resale of up to 6,106,870 shares of common stock by selling stockholders, following a private placement that closed on October 19, 2026, raising approximately $200 million in gross proceeds at $32.75 per share. The company…

Subscribe for Full Access